Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for sleep quality and cognitive function in hemodialysis patients
IRCT20211030052917N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in sleep disorder and confusion (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Sleep quality in patients undergoing hemodialysis and Cognitive function in patients undergoing hemodialysis. Started Nov 2021; status: completed.
02
Drugs
melatonin
03
Conditions
sleep disorderconfusion
Beyond the preview
Go deeper on IRCT20211030052917N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211030052917N1.